NASDAQ:RTIX - RTI Surgical Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.73 -0.22 (-3.70 %) (As of 03/22/2019 04:00 PM ET)Previous Close$5.95Today's Range$5.7250 - $5.9752-Week Range$3.51 - $6.04Volume153,702 shsAverage Volume188,813 shsMarket Capitalization$357.05 millionP/E Ratio47.75Dividend YieldN/ABeta1.32 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email RTI Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes. The company's implants are used in the fields of sports medicine, general surgery, spine, orthopedic, trauma, and cardiothoracic procedures to repair and promote the natural healing of human bone and other human tissues; and to enhance surgical outcomes. It markets its products through its direct distribution force, as well as through a network of independent distributors. The company was formerly known as RTI Biologics, Inc. and changed its name to RTI Surgical, Inc. in July 2013. RTI Surgical, Inc. was founded in 1997 and is headquartered in Alachua, Florida. Receive RTIX News and Ratings via Email Sign-up to receive the latest news and ratings for RTIX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical appliances & supplies Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:RTIX Previous Symbol CUSIP74975N10 CIK1100441 Webwww.rtix.com Phone386-418-8888Debt Debt-to-Equity Ratio0.27 Current Ratio3.14 Quick Ratio1.22Price-To-Earnings Trailing P/E Ratio47.75 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$280.86 million Price / Sales1.27 Cash Flow$0.2980 per share Price / Cash Flow19.23 Book Value$2.89 per share Price / Book1.98Profitability EPS (Most Recent Fiscal Year)$0.12 Net Income$-1,250,000.00 Net Margins-0.45% Return on Equity4.30% Return on Assets2.19%Miscellaneous Employees891 Outstanding Shares62,313,000Market Cap$357.05 million Next Earnings Date5/2/2019 (Estimated) OptionableOptionable RTI Surgical (NASDAQ:RTIX) Frequently Asked Questions What is RTI Surgical's stock symbol? RTI Surgical trades on the NASDAQ under the ticker symbol "RTIX." How were RTI Surgical's earnings last quarter? RTI Surgical Inc (NASDAQ:RTIX) announced its quarterly earnings results on Thursday, February, 28th. The medical equipment provider reported $0.04 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.01 by $0.03. RTI Surgical had a negative net margin of 0.45% and a positive return on equity of 4.30%. View RTI Surgical's Earnings History. When is RTI Surgical's next earnings date? RTI Surgical is scheduled to release their next quarterly earnings announcement on Thursday, May 2nd 2019. View Earnings Estimates for RTI Surgical. What guidance has RTI Surgical issued on next quarter's earnings? RTI Surgical updated its FY 2019 earnings guidance on Thursday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $325-335 million, compared to the consensus revenue estimate of $285.4 million. What price target have analysts set for RTIX? 1 equities research analysts have issued 1-year price objectives for RTI Surgical's stock. Their forecasts range from $8.00 to $8.00. On average, they anticipate RTI Surgical's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 39.6% from the stock's current price. View Analyst Price Targets for RTI Surgical. What is the consensus analysts' recommendation for RTI Surgical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RTI Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RTI Surgical. Has RTI Surgical been receiving favorable news coverage? Press coverage about RTIX stock has trended neutral recently, InfoTrie reports. The research group rates the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. RTI Surgical earned a news impact score of 0.5 on InfoTrie's scale. They also assigned headlines about the medical equipment provider a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the next several days. Who are some of RTI Surgical's key competitors? Some companies that are related to RTI Surgical include Establishment Labs (ESTA), Invacare (IVC), Sientra (SIEN), ConforMIS (CFMS), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), Rewalk Robotics (RWLK), NanoVibronix (NAOV), Wound Management Technologies (WNDM), Precision Therapeutics (AIPT), Bionik Laboratories (BNKL), Histogenics (HSGX), Allied Healthcare Products (AHPI), Avitar (AVTI) and Halyard Health (HYH). What other stocks do shareholders of RTI Surgical own? Based on aggregate information from My MarketBeat watchlists, some companies that other RTI Surgical investors own include LightPath Technologies (LPTH), Progenics Pharmaceuticals (PGNX), Rigel Pharmaceuticals (RIGL), Inovio Pharmaceuticals (INO), Catalyst Pharmaceuticals (CPRX), Synergy Pharmaceuticals (SGYP), Eyepoint Pharmaceuticals (EYPT), Endocyte (ECYT), ZIOPHARM Oncology (ZIOP) and Amicus Therapeutics (FOLD). Who are RTI Surgical's key executives? RTI Surgical's management team includes the folowing people: Mr. Camille I. Farhat, CEO, Pres & Director (Age 49)Mr. Jonathon M. Singer, Chief Financial & Admin. Officer and Corp. Sec. (Age 55)Mr. John N. Varela, Exec. VP of Global Operations (Age 52)Mr. Tony Lemus, VP of Global R&D, Clinical and RegulatoryMs. Molly Poarch, Director of Corp. Communications Who are RTI Surgical's major shareholders? RTI Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.89%), Dimensional Fund Advisors LP (7.64%), Dimensional Fund Advisors LP (7.64%), Krensavage Asset Management LLC (7.16%), Krensavage Asset Management LLC (7.14%) and Royce & Associates LP (1.54%). Company insiders that own RTI Surgical stock include Camille Farhat, John N Varela, Jonathon M Singer, Kevin D Brandt, Mark Stolper, Nicholas J Valeriani, Shirley A Weis and Thomas Mceachin. View Institutional Ownership Trends for RTI Surgical. Which institutional investors are selling RTI Surgical stock? RTIX stock was sold by a variety of institutional investors in the last quarter, including Rutabaga Capital Management LLC MA, Millennium Management LLC, Royce & Associates LP, Algert Global LLC, Kopp Investment Advisors LLC, Two Sigma Investments LP, Krensavage Asset Management LLC and D. E. Shaw & Co. Inc.. View Insider Buying and Selling for RTI Surgical. Which institutional investors are buying RTI Surgical stock? RTIX stock was purchased by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan, Boston Partners, Alambic Investment Management L.P., Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Los Angeles Capital Management & Equity Research Inc., BlackRock Inc. and Segall Bryant & Hamill LLC. Company insiders that have bought RTI Surgical stock in the last two years include Camille Farhat, John N Varela, Jonathon M Singer, Kevin D Brandt, Mark Stolper, Nicholas J Valeriani, Shirley A Weis and Thomas Mceachin. View Insider Buying and Selling for RTI Surgical. How do I buy shares of RTI Surgical? Shares of RTIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is RTI Surgical's stock price today? One share of RTIX stock can currently be purchased for approximately $5.73. How big of a company is RTI Surgical? RTI Surgical has a market capitalization of $357.05 million and generates $280.86 million in revenue each year. The medical equipment provider earns $-1,250,000.00 in net income (profit) each year or $0.12 on an earnings per share basis. RTI Surgical employs 891 workers across the globe. What is RTI Surgical's official website? The official website for RTI Surgical is http://www.rtix.com. How can I contact RTI Surgical? RTI Surgical's mailing address is 11621 RESEARCH CIRCLE, ALACHUA FL, 32615. The medical equipment provider can be reached via phone at 386-418-8888 or via email at [email protected] MarketBeat Community Rating for RTI Surgical (NASDAQ RTIX)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 227 (Vote Outperform)Underperform Votes: 281 (Vote Underperform)Total Votes: 508MarketBeat's community ratings are surveys of what our community members think about RTI Surgical and other stocks. Vote "Outperform" if you believe RTIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RTIX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: How is a Moving Average Calculated?